The Boston Globe
Hazardous Air Quality in Chicago Prompts Beach, Pool Closures and Outdoor Event Cancellations
Opinion: Teaching US History to Immigrant Students at Chelsea High School
Chloe Fineman Leaving 'SNL' After Seven Seasons
Canadian smoke subsides as Boston skies begin to clear, weather forecast indicates
Trump administration limits duration of stay for international students in the US
المصدر: The Boston Globe
24 Hrsجاهز للتشغيل
جاهز للتشغيل
Kalshi, a prediction market exchange, announced it will begin testing markets on clinical trial outcomes and FDA approval decisions, initially focusing on late-stage Phase 3 trials conducted by established biopharma companies. The company aims to provide a new tool for investors and improve drug development decisions while implementing safeguards to prevent insider trading and trial manipulation. Experts express concerns about potential risks to trial integrity and the actual usefulness of predictions, especially in early-stage research, but Kalshi aims to expand into more uncertain areas in the future.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading